ong-term prognosis of medical treatment on sick below-the-knee disease without critical limb ischemia
Not Applicable
- Conditions
- Arteriosclerotic obliterans
- Registration Number
- JPRN-UMIN000002346
- Lead Sponsor
- Shinkawabashi Hospital, Cardiovascular center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
1) No revascularization history of above-the-knee artery disease 2) Revascularization history of below-the-knee artery disease 3) Critical limb ischemia 4) Acute limb ischemia 5) Poor prognosis status (such as malignancy or low ejection fraction<30%)
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Death, Limb amputation, Critical limb ischemia, Myocardial infarction, Revascularization(Endovascular tharepy, Bypass surgery), Stroke
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the progression of arteriosclerotic obliterans in below-the-knee disease patients without critical limb ischemia?
How does medical treatment in JPRN-UMIN000002346 compare to standard-of-care therapies for non-critical limb ischemia arteriosclerosis?
Are specific biomarkers associated with improved long-term prognosis in patients with below-the-knee arteriosclerotic obliterans?
What are the potential adverse events of long-term medical management for non-critical below-the-knee arterial disease?
What combination therapies or novel drug targets are being explored for peripheral arterial disease similar to JPRN-UMIN000002346?